World Meat and Poultry: Chicken Pox - Pipeline Review, H2 2011

• Publication date: November 2011

This report provides information on the therapeutic development for Chicken Pox, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chicken Pox. '' is built using data and information sourced from Global Industries Direct’s proprietary databases, Firms /University websites, SEC filings, investor presentations and featured press relea...

This report provides information on the therapeutic development for Chicken Pox, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chicken Pox. '' is built using data and information sourced from Global Industries Direct’s proprietary databases, Firms /University websites, SEC filings, investor presentations and featured press releases from firm /university sites and market -specific third party sources, put together by Global Industries Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope of the Research

- A snapshot of the global therapeutic scenario for Chicken Pox.
- A review of the Chicken Pox products under development by industry players and universities/research institutes based on information derived from industry player and market -specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Chicken Pox pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Identify and understand important and diverse types of therapeutics under development for Chicken Pox.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and take over s effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Chicken Pox pipeline depth and focus of Chicken Pox therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and grow business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Global Meat And Poultry Industry

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global March kets Direct Report Coverage 4
Chicken Pox Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Chicken Pox 6
Chicken Pox Therapeutics under Development by Firms 8
Late Stage Products 9
Comparative Analysis 9
Pre-Clinical Stage Products 10
Comparative Analysis 10
Chicken Pox Therapeutics - Products under Development by Firms 11
Companies Involved in Chicken Pox Therapeutics Development 12
GlaxoSmithKline plc 12
Sinovac Biotech Ltd. 12
Chicken Pox - Therapeutics Assessment 13
Assessment by Monotherapy Products 13
Assessment by Combination Products 14
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Drug Profiles 19
Chickenpox Vaccine - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Varilrix + Priorix-Tetra - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 22
Contact Us 22
Disclaimer 22

List of Tables

Number of Products Under Development for Chicken Pox, H2 2011 6
Products under Development for Chicken Pox – Comparative Analysis, H2 2011 7
Number of Products under Development by Firms, H2 2011 8
Comparative Analysis by Late Stage Development, H2 2011 9
Comparative Analysis by Pre-Clinical Stage Development, H2 2011 10
Products under Development by Firms, H2 2011 11
GlaxoSmithKline plc, H2 2011 12
Sinovac Biotech Ltd., H2 2011 12
Assessment by Monotherapy Products, H2 2011 13
Assessment by Combination Products 14
Assessment by Stage and Route of Administration, H2 2011 16
Assessment by Molecule Type, H2 2011 18

List of Figures

Number of Products under Development for Chicken Pox, H2 2011 6
Products under Development for Chicken Pox – Comparative Analysis, H2 2011 7
Products under Development by Firms, H2 2011 8
Late Stage Products, H2 2011 9
Pre-Clinical Stage Products, H2 2011 10
Assessment by Monotherapy Products, H2 2011 13
Assessment by Combination Products, H2 2011 14
Assessment by Route of Administration, H2 2011 15
Assessment by Stage and Route of Administration, H2 2011 16
Assessment by Molecule Type, H2 2011 17
Assessment by Stage and Molecule Type, H2 2011 18